Laura Feeney

1.0k total citations
30 papers, 383 citations indexed

About

Laura Feeney is a scholar working on Surgery, Oncology and Molecular Biology. According to data from OpenAlex, Laura Feeney has authored 30 papers receiving a total of 383 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 12 papers in Oncology and 7 papers in Molecular Biology. Recurrent topics in Laura Feeney's work include Salivary Gland Tumors Diagnosis and Treatment (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and DNA Repair Mechanisms (3 papers). Laura Feeney is often cited by papers focused on Salivary Gland Tumors Diagnosis and Treatment (7 papers), Cancer Immunotherapy and Biomarkers (5 papers) and DNA Repair Mechanisms (3 papers). Laura Feeney collaborates with scholars based in United Kingdom, United States and South Korea. Laura Feeney's co-authors include Benjamin Jacobs, Christophe Lachaud, Iván Muñoz, Rachel Toth, Eric A. Stauffer, John Rouse, Paul L. Appleton, Elaine Reynolds, Detlev Schindler and Aaron C. Moberly and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Molecular Cell.

In The Last Decade

Laura Feeney

24 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Feeney United Kingdom 11 104 93 82 50 40 30 383
Teresa Nutile Italy 14 159 1.5× 24 0.3× 20 0.2× 52 1.0× 44 1.1× 23 505
Xiaoti Lin China 15 314 3.0× 73 0.8× 73 0.9× 9 0.2× 212 5.3× 28 728
Elly Lynch Australia 12 137 1.3× 139 1.5× 43 0.5× 66 1.3× 60 1.5× 26 597
Timothy H. Schmidt United States 8 158 1.5× 51 0.5× 20 0.2× 10 0.2× 11 0.3× 11 549
Katherine Rose United States 10 180 1.7× 21 0.2× 64 0.8× 24 0.5× 35 0.9× 22 427
F. George Otieno United States 12 307 3.0× 34 0.4× 87 1.1× 37 0.7× 79 2.0× 14 966
Fiona James United Kingdom 7 112 1.1× 156 1.7× 23 0.3× 8 0.2× 61 1.5× 15 499
Junqiang Dai United States 17 243 2.3× 132 1.4× 44 0.5× 62 1.2× 115 2.9× 54 684
Nofrat Schwartz United States 12 70 0.7× 73 0.8× 60 0.7× 14 0.3× 44 1.1× 23 338

Countries citing papers authored by Laura Feeney

Since Specialization
Citations

This map shows the geographic impact of Laura Feeney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Feeney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Feeney more than expected).

Fields of papers citing papers by Laura Feeney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Feeney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Feeney. The network helps show where Laura Feeney may publish in the future.

Co-authorship network of co-authors of Laura Feeney

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Feeney. A scholar is included among the top collaborators of Laura Feeney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Feeney. Laura Feeney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Soonjoung, Shintaro Yamada, Tao Li, et al.. (2025). Mouse MRE11-RAD50-NBS1 is needed to start and extend meiotic DNA end resection. Nature Communications. 16(1). 3613–3613. 5 indexed citations
2.
McCluggage, W. Glenn, et al.. (2024). The malignant transformation of endometriosis: Is there a left lateral predisposition of ovarian clear cell and endometrioid carcinomas?. European Journal of Surgical Oncology. 50(6). 108247–108247. 1 indexed citations
3.
4.
Feeney, Laura, et al.. (2024). Early Onset Pancytopenia Post Heart Transplant: Calcineurin Inhibitor-Induced Thrombotic Microangiopathy versus Cytomegalovirus Infection. The Journal of Heart and Lung Transplantation. 43(4). S534–S534.
5.
Feeney, Laura, Anita Lavery, Conor O’Neill, et al.. (2023). Real world outcomes in cancer patients with COVID-19 infection: Northern Ireland experience.. PubMed. 92(1). 29–37. 1 indexed citations
6.
Olsson‐Brown, Anna, Mark Baxter, Laura Feeney, et al.. (2022). The association of pre-existing autoimmune disease and immune-related adverse events secondary to immune checkpoint inhibition therapy in a UK multicenter cohort.. Journal of Clinical Oncology. 40(16_suppl). 2522–2522.
7.
Feeney, Laura, Helen Adderley, David Morgan, et al.. (2022). Clinical disease course and survival outcomes following disease recurrence in adenoid cystic carcinoma with and without NOTCH signaling pathway activation. Oral Oncology. 133. 106028–106028. 19 indexed citations
8.
Feeney, Laura, Helen Adderley, Guy Betts, et al.. (2022). Evaluation of the Clinical Utility of Genomic Profiling to Inform Selection of Clinical Trial Therapy in Salivary Gland Cancer. Cancers. 14(5). 1133–1133. 9 indexed citations
9.
10.
Feeney, Laura, Matthew Beasley, Oliver Donnelly, et al.. (2021). Centralised RECIST Assessment and Clinical Outcomes with Lenvatinib Monotherapy in Recurrent and Metastatic Adenoid Cystic Carcinoma. Cancers. 13(17). 4336–4336. 14 indexed citations
11.
Feeney, Laura, et al.. (2021). An evaluation of the process of informed consent: views from research participants and staff. Trials. 22(1). 544–544. 19 indexed citations
12.
Olsson‐Brown, Anna, Mark Baxter, Caroline Dobeson, et al.. (2021). Real-world outcomes in older adults treated with immunotherapy: A United Kingdom multicenter series of 2,049 patients.. Journal of Clinical Oncology. 39(15_suppl). 12026–12026. 5 indexed citations
13.
Feeney, Laura, et al.. (2020). Liquid biopsy in ovarian cancer: Catching the silent killer before it strikes. World Journal of Clinical Oncology. 11(11). 868–889. 29 indexed citations
14.
Olsson‐Brown, Anna, Mark Baxter, Caroline Dobeson, et al.. (2020). Real-world outcomes of immune-related adverse events in 2,125 patients managed with immunotherapy: A United Kingdom multicenter series.. Journal of Clinical Oncology. 38(15_suppl). 7065–7065. 6 indexed citations
15.
Adderley, Helen, Laura Feeney, Deborah Morgan, et al.. (2020). The utility of TP53 and PIK3CA mutations as prognostic biomarkers in salivary adenoid cystic carcinoma. Oral Oncology. 113. 105095–105095. 18 indexed citations
16.
McArt, Darragh G., Jennifer S. Ferris, Niamh E. Buckley, et al.. (2019). Defining the molecular evolution of extrauterine high grade serous carcinoma. Gynecologic Oncology. 155(2). 305–317. 17 indexed citations
17.
Doyle, Joseph, et al.. (2019). Clinical decision support for high-cost imaging: A randomized clinical trial. PLoS ONE. 14(3). e0213373–e0213373. 36 indexed citations
18.
Feeney, Laura, Iván Muñoz, Christophe Lachaud, et al.. (2017). RPA-Mediated Recruitment of the E3 Ligase RFWD3 Is Vital for Interstrand Crosslink Repair and Human Health. Molecular Cell. 66(5). 610–621.e4. 60 indexed citations
19.
Wilund, Kenneth R., et al.. (2008). Endurance exercise training reduces gallstone development in mice. Journal of Applied Physiology. 104(3). 761–765. 32 indexed citations
20.
Reynolds, Elaine, et al.. (2003). Treatment with the antiepileptic drugs phenytoin and gabapentin ameliorates seizure and paralysis ofDrosophilabang‐sensitive mutants. Journal of Neurobiology. 58(4). 503–513. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teresa Nutile Breakdown of academic impact, for papers by Xiaoti Lin Breakdown of academic impact, for papers by Elly Lynch Breakdown of academic impact, for papers by Timothy H. Schmidt Breakdown of academic impact, for papers by Katherine Rose Breakdown of academic impact, for papers by F. George Otieno Breakdown of academic impact, for papers by Fiona James Breakdown of academic impact, for papers by Junqiang Dai Breakdown of academic impact, for papers by Nofrat Schwartz
Rankless by CCL
2026